CIDRAP newsletters options
The group is expected to vote on thimerosal, despite no evidence of harm, and will discuss the MMRV use in young children.
In other developments, New Mexico reported another wastewater detection and South Dakota expanded MMR vaccine clinics after confirming two more infections.
In an effort to combat misinformation, a group of volunteers have compiled a growing list of randomized controlled trials conducted for licensed vaccines.
An analysis of FDA data found over one-third of US retail meat samples tested positive for potentially harmful bacteria, and nearly 1 in 4 bacterial isolates collected were multidrug-resistant.
The FDA says the Commissioner's National Priority Voucher program will shorten the review time for eligible drug candidates from nearly a year to 1-2 months.
30.6% of ICU patients experienced CMV reactivation.
Former ACIP members pushed back on claims of public mistrust and warned dismantling has critically weakened US vaccination programs.
Among the participants in the present study, 972 developed acute kidney injury.
The authors saw a greater reduction and more extended fluctuations in sleep duration among people reporting long COVID with sleep problems.
Mexico's Ministry of Health has reported five new cases of the parasitic disease screwworm myiasis, bringing the country's total to 13 cases.
Health officials across a wide swath of the country are probing exposures linked to air, rail, and bus travel.
The study of more than 20,000 children in Iceland found those with early antibiotic exposure had increased risk of respiratory, gastrointestinal, and urinary tract infections compared with those who had no exposure.
The patient's neighbor had chickens, but no illnesses or deaths were reported in the flock.
The FDA is investigating whether other lots or products made by the Turkish company are impacted.
In other developments, Dallas County has reported its first case since 2019, a vaccinated adult whose exposure is still under investigation.
The probability of any dengue complication was 20%, with risks of specific complications of up to 230%.
In other developments, the ECDC today reported a slow rise in COVID activity in the Europe, which may partly reflect waning population immunity.
The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease.
The cholera outbreak in Sudan's Khartoum State has resulted in 16,000 cases and 239 deaths since May.
The announcement comes just 2 days after Kennedy removed all 17 members of the Centers for Disease Control and Prevention's vaccine advisory committee.
